Cullinan Therapeutics is dedicated to creating new standards of care for patients.
We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class.
Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.
Notice to Job Seekers: Job applicants should be aware of job recruitment, interview and offer scams being perpetrated through the use of the internet and social media platforms. To learn more, visit our Careers page or read Cullinan’s Employment Recruitment Scams Notice here: https://cullinantherapeutics.com/docs/employment-recruitment-scams-notice.pdf
Company Details
- Employees
- 134
- Address
- 1 Main St, Cambridge,massachusetts 02142,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Oncology and Auto-Immune Diseases.
- HQ
- Cambridge, Massachusetts
Cullinan Therapeutics Questions
Cullinan Therapeutics's website is http://www.cullinantherapeutics.com
Cullinan Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cullinantx
Cullinan Therapeutics has
134 employees.
View email and phone details for 134
employees at Cullinan Therapeutics.
Cullinan Therapeutics's industry is
Biotechnology Research
Cullinan Therapeutics's top competitors are
Bridgebio,
Kura Oncology, Inc.,
Sarepta Therapeutics,
Viridian Therapeutics, Inc.,
Scholar Rock,
Alnylam Pharmaceuticals,
Vertex Pharmaceuticals,
Metsera,
Aura Biosciences,
Syros Pharmaceuticals.
Cullinan Therapeutics's categories are Biotechnology Research
